Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01DIT
|
|||
| Former ID |
DNC013700
|
|||
| Drug Name |
N-(2-hydroxyethyl)linoleoylamide
|
|||
| Synonyms |
Linoleamide MEA; Linoleoyl ethanolamide; Linoleic ethanolamide; n-linoleoylethanolamine; N-(2-Hydroxyethyl)linoleamide; Anandamide (18:2, n-6); Linoleoyl monoethanolamide; UNII-889DYX0816; N-(2-hydroxyethyl)linoleoylamide; Linoleylethanolamide; 68171-52-8; Monoethanolamine linoleic acid amide; EINECS 269-029-6; N-(9Z,12Z-octadecadienoyl)-ethanolamine; CHEMBL149859; N-(2-Hydroxyethyl)-linoleamide; C20H37NO2; CHEBI:64032; 889DYX0816; (9Z,12Z)-N-(2-Hydroxyethyl)octadeca-9,12-dien-1-amide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H37NO2
|
|||
| Canonical SMILES |
CCCCCC=CCC=CCCCCCCCC(=O)NCCO
|
|||
| InChI |
1S/C20H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h6-7,9-10,22H,2-5,8,11-19H2,1H3,(H,21,23)/b7-6-,10-9-
|
|||
| InChIKey |
KQXDGUVSAAQARU-HZJYTTRNSA-N
|
|||
| CAS Number |
CAS 68171-52-8
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:64032
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Radiosynthesis, in vitro and in vivo evaluation of 123I-labeled anandamide analogues for mapping brain FAAH. Bioorg Med Chem. 2009 Jan 1;17(1):49-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.